Companies ›Healthcare ›8143.HK

8143.HK — HKEX Healthcare Facilities & Services

8143.Hk

HK$0,07

Open in Charts → Attach watcher ⌖

— —

HKD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

-44,5 %

ROE

155,6 %

Net margin

-62,8 %

Debt / equity

-1,62

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

The company operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the development, production, and sale of pharmaceutical products.

Business. The company operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the development, production, and sale of pharmaceutical products.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

155,6 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning 8143.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to 8143.HK. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

AI synthesis

GENERATED

The company's capital structure is characterized by a negative total equity of -6,509,000 HKD and a debt-to-equity ratio of -1.62, indicating a significant reliance on debt financing. Despite a negative net income of -10,127,000 HKD, the company maintains a positive operating cash flow of 2,622,000 HKD and free cash flow of 1,641,000 HKD, suggesting some liquidity to support operations.

Profitability metrics reveal a return on equity of 1.5558, which is relatively low given the company's negative equity position. The return on assets is -1.03, indicating that the company is not generating a positive return on its asset base. These figures suggest that the company is underperforming in terms of profitability compared to industry norms.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk associated with the company's revenue streams. The absence of segment-specific data limits the ability to assess the performance of different parts of the business.

The company's growth trajectory is uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's operating cash flow and free cash flow suggest some capacity to fund operations and potentially invest in growth initiatives. The capital expenditure of -41,000 HKD indicates minimal investment in new assets, which may limit future growth potential.

The company faces several risk factors, including a negative net cash position after subtracting total debt. This liquidity risk is compounded by the company's negative equity, which could lead to financial distress if not addressed. The dilution risk is currently assessed as low, but the company's financial position may necessitate future equity issuances, which could dilute existing shareholders' ownership.

Recent events, such as the company's financial performance and capital structure, are reflected in the latest financial filings. The company's negative net income and reliance on debt financing highlight the need for strategic financial management to improve its financial health.

Key takeaways

The company has a negative equity position, indicating a significant reliance on debt financing.
Despite a negative net income, the company maintains positive operating and free cash flows, suggesting some liquidity.
The company's profitability metrics are weak, with a low return on equity and a negative return on assets.
The company's revenue is concentrated in a single segment, increasing its exposure to market risks.
The company's liquidity risk is medium, and its financial position may require future equity issuances to address debt obligations.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

HK$0,07

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

-HK$6.5M

Net cashⓘ

-HK$6.7M

Current ratioⓘ

0.5

Debt / equityⓘ

-1.6

ROAⓘ

-1.0%

ROEⓘ

1.6%

Cash conversionⓘ

-26.0%

CapEx / revenueⓘ

-0.2%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin-44,5 %Bottom quartile

Net Margin-62,8 %Bottom quartile

ROE155,6 %Best in class

Capex / Rev-0,2 %Above P75

D/E-1,62Best in class

Cash Conv-0,26Bottom quartile

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

8143.HK Market data — financials · 2026-05-27

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

8143.HKCanonical

HKEX · HKD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread